Aurinia Pharmaceuticals (AUPH) Depreciation and Depletion (2020 - 2024)

Aurinia Pharmaceuticals has reported Depreciation and Depletion for 5 years, with the latest figure at -$14.0 million in Q4 2024.

• For the quarter ending Q4 2024, Depreciation and Depletion fell 129.3% year-over-year to -$14.0 million; the trailing twelve-month figure through Dec 2024 stood at $600000.0 (changed 0.0% YoY), and the FY2025 full-year result was $600000.0, changed 0.0% from the prior year.
• Depreciation and Depletion for Q4 2024 stood at -$14.0 million, down from $4.9 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $5.3 million in Q3 2023, with the low at -$14.0 million in Q4 2024.
• Historically, Depreciation and Depletion has averaged $84166.7 across 5 years, with a median of $687000.0 in 2022.
• The largest YoY upside for Depreciation and Depletion was 5633.33% in 2021 against a maximum downside of 7494.44% in 2021.
• Aurinia Pharmaceuticals' Depreciation and Depletion stood at -$18000.0 in 2020, then slumped by 7494.44% to -$1.4 million in 2021, then sank by 38.04% to -$1.9 million in 2022, then tumbled by 223.16% to -$6.1 million in 2023, then sank by 129.3% to -$14.0 million in 2024.
• The last three Depreciation and Depletion figures came in at -$14.0 million (Q4 2024), $4.9 million (Q3 2024), and $4.8 million (Q2 2024), per Business Quant data.